TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c
Tweet
Share
E-mailGet Alerts TLSI Hot Sheet
Join SI Premium – FREE
TriSalus Life Sciences (NASDAQ: TLSI) reported Q3 EPS of ($0.96). Revenue for the quarter came in at $11.6 million.
For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
- Dell (DELL) PT Raised to $575 at Evercore ISI
- Goldman Sachs Upgrades Deutsche Bank (DBK:GR) (DB) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
